Afatinib Plus Chemotherapy Against Esophageal or Lung Squamous Cell Carcinoma

NCT03486509 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

2

Enrollment

OTHER_GOV

Sponsor class

Conditions

Squamous Cell Carcinoma

Interventions

DRUG: Afatinib

Sponsor

Fujian Cancer Hospital